Clinical application of chemiluminescence enzyme immunoassay to quantitatively detect human thyroid peroxidase antibodies

Jinyan Chai,Peihua Fang,Jian Tan,Ning Li
DOI: https://doi.org/10.3760/cma.j.issn.1673-4157.2016.01.006
2016-01-01
International Journal of Endocrinology and Metabolism
Abstract:Objective To apply chemiluminescence enzyme immunoassay (CLEIA) kits of thyroid peroxidase antibodies (hTPOAb) on normal and all kinds of patients with thyroid diseases, and explore the clinical value of the kits.Methods The hTPOAb kits were used in 333 cases of serum samples, including 133 cases of healthy people, 94 cases of Hashimoto's thyroiditis(HT) ,68 cases of Graves' disease(GD), 19 cases of nodular goiter, 10 cases of subacute thyroiditis and 9 cases of simple goiter.Results Concentration above 3.22 IU/ml was considered to be positive of the hTPOAb kits.The median concentration of hTPOAb was 5.48 IU/ml in HT (positive ratio was 91.50%), 1.88 IU/ml in GD (positive ratio was 29.40%), 1.83 IU/ml in nodular goiter(positive ratio was 10.50%) ,2.54 IU/ml in subacute thyroiditis(positive ratio was 20.00%) ,and 2.21 IU/ml in simple goiter(positive ratio was 0).The positive ratio of hTPOAb in patients with HT was higher than that of the other patients (x2 =67.22,60.13,35.49,49.89, all P < 0.01).Conclusion The CLEIA kits of hTPOAb has a high positive rate for HT, and is an effective method in diagnosing HT.
What problem does this paper attempt to address?